HP Ingredients Resumes Marketing of LJ100

BRADENTON, Fla. HP Ingredients announced it ended its distribution contract with SourceOne Global Partners, covering the distribution of LJ100® Eurycoma longifolia extract, a patented ingredient studied for its ability to influence hormone levels, improve energy and exert anti-aging effects. HP Ingredients is currently collaborating with Biotropics on two randomized, double blind, placebo-controlled human clinical trials using LJ100, both to be completed by early 2010. One trial will involve 100 male subjects to examine LJ100s effects on fat loss, sexual health, hormonal profile and safety. The second double blind, placebo-controlled trial will involve 26 men with mild erectile dysfunction, with the goal of measuring the effects of a combination of LJ100 and Polygonum minus on sexual performance, quality of life, testosterone level, weight loss and safety.